The Centre on Tuesday said it was examining the applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their vaccines. It asserted that Drugs Controller General of India (DCGI) seeking more data from these companies will not impact the vaccine-roll out timeline.